Brimonidine

Profiles Drug Subst Excip Relat Methodol. 2023:48:1-37. doi: 10.1016/bs.podrm.2022.11.001. Epub 2023 Feb 24.

Abstract

Brimonidine is a highly selective 2-adrenoceptor agonist that lowers intraocular pressure (IOP) by decreasing aqueous humor production and increasing aqueous humor outflow via the uveoscleral route. Brimonidine is used to treat glaucoma and other eye conditions. Brimonidine is a topical medication that is used mainly to treat open-angle glaucoma and ocular hypertension in the eyelids. The purpose of this chapter is to provide a comprehensive discussion of Brimonidine's nomenclature, physiochemical properties, preparation methods, identification procedures, and numerous qualitative and quantitative analytical techniques, as well as its ADME profiles and pharmacological effects. In addition, the chapter contains numerous approaches for separating brimonidine from other medications in combination formulations utilizing chromatographic techniques and other spectroscopic approaches.

Keywords: Brimonidine; Clinical pharmacology; HPLC; Methods of preparation; Ocular hypertension on the eyelids; Open-angle glaucoma; Selective 2-adrenoceptor agonist; Spectrometric analysis.

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic alpha-Agonists / therapeutic use
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • Brimonidine Tartrate / pharmacology
  • Brimonidine Tartrate / therapeutic use
  • Glaucoma* / drug therapy
  • Glaucoma, Open-Angle* / drug therapy
  • Humans
  • Ophthalmic Solutions / therapeutic use
  • Quinoxalines / pharmacology
  • Quinoxalines / therapeutic use

Substances

  • Brimonidine Tartrate
  • Adrenergic alpha-Agonists
  • Quinoxalines
  • Ophthalmic Solutions
  • Antihypertensive Agents